InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: brianc22 post# 110017

Monday, 11/24/2014 5:44:36 PM

Monday, November 24, 2014 5:44:36 PM

Post# of 130501
Win-Win for both companies. Reginicin will use this money to pay off debt as well as develope new pipeline at the expense of PermaDerm whereas Amarantus will bring PermaDerm to market with help from Lonza. Lonza spent 10 million to make PermaDerm GMP compliant and is ready for phase II with proven results. The timing couldn't have been better for AMBS. JMO